NovoBind Livestock Therapeutics is an agri-biotech company working to combat rising resistance to anti-infectives and their accumulating residue in the environment. We do this by developing next-generation biologics that target and neutralize the specific bacteria, viruses, and parasites that cause intestinal ailments in livestock, aquaculture, and pets. Our novel biotherapeutic solutions are based on nanobodies (or single domain antibodies) and provide a complementary alternative to conventional treatments.
We are continually expanding the team with exceptional, passionate and purposeful colleagues. Our aim is to have a global impact with sustainable practices. We are currently looking for:
COVID-19 ACTION PLAN
We are joining forces in the war on COVID-19 with a unique open source model. We’re donating our resources to develop custom nanobodies* for others to use in developing diagnostics and therapeutics that have a meaningful impact.
*Trademarked by Ablynx